Karine Belleville
Sherbrooke, QC J1H5N4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Improved brain penetration of neurotensin(8-13) via blood-brain barrier shuttle conjugation underlies strong analgesia.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 05, 2026
A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitor.
Journal: Pharmacological research
Published: August 23, 2024
Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain.
Journal: The Journal of pharmacology and experimental therapeutics
Published: November 03, 2019
Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain.
Journal: Pharmacological research
Published: October 23, 2019
A Systematic Exploration of Macrocyclization in Apelin-13: Impact on Binding, Signaling, Stability, and Cardiovascular Effects.
Journal: Journal of medicinal chemistry
Published: February 21, 2018
A two-hit model of suicide-trait-related behaviors in the context of a schizophrenia-like phenotype: Distinct effects of lithium chloride and clozapine.
Journal: Physiology & behavior
Published: October 01, 2015
Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.
Journal: The Journal of clinical investigation
Published: April 26, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026